| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| TSBP1 |
Q5SRN2
|
testis expressed basic protein 1
|
|
1.5E-16 |
0.638 |
0.692 |
| GGNBP1 |
Q5YKI7
|
gametogenetin binding protein 1 (pseudogene)
|
|
0.69 |
0.769 |
0.462 |
| MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
| PCAT1 |
|
prostate cancer associated transcript 1
|
|
|
0.575 |
0.615 |
| MYNN |
Q9NPC7
|
myoneurin
|
|
0.57 |
0.722 |
0.423 |
| DRAIC |
|
downregulated RNA in cancer, inhibitor of cell invasion and migration
|
|
|
0.736 |
0.423 |
| FARP2 |
O94887
|
FERM, ARH/RhoGEF and pleckstrin domain protein 2
|
|
4.6E-36 |
0.678 |
0.615 |
| SP140 |
Q13342
|
SP140 nuclear body protein
|
|
5.0E-08 |
0.691 |
0.577 |
| FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
| GRAMD1B |
Q3KR37
|
GRAM domain containing 1B
|
|
1.00 |
0.736 |
0.385 |
| CASC19 |
|
cancer susceptibility 19
|
|
|
0.769 |
0.423 |
| FKRP |
Q9H9S5
|
fukutin related protein
|
|
9.8E-06 |
0.513 |
0.731 |
| IPCEF1 |
Q8WWN9
|
interaction protein for cytohesin exchange factors 1
|
|
1.6E-03 |
0.821 |
0.269 |
| C11orf21 |
Q9P2W6
|
chromosome 11 open reading frame 21
|
|
1.6E-02 |
0.821 |
0.192 |
| HDLBP |
Q00341
|
high density lipoprotein binding protein
|
|
1.00 |
0.636 |
0.731 |
| ACOXL-AS1 |
|
ACOXL antisense RNA 1
|
|
|
0.861 |
0.154 |
| LEF1 |
Q9UJU2
|
lymphoid enhancer binding factor 1
|
|
1.00 |
0.486 |
0.769 |
| ACTA2 |
P62736
|
actin alpha 2, smooth muscle
|
Cellular structure
|
0.93 |
0.508 |
0.846 |
| CLPTM1L |
Q96KA5
|
CLPTM1 like
|
Enzyme
|
4.4E-05 |
0.551 |
0.654 |
| ACOXL |
Q9NUZ1
|
acyl-CoA oxidase like
|
Enzyme
|
5.2E-15 |
0.674 |
0.577 |
| CASP8 |
Q14790
|
caspase 8
|
Enzyme
|
3.7E-06 |
0.404 |
0.923 |
| QPCT |
Q16769
|
glutaminyl-peptide cyclotransferase
|
Enzyme
|
1.2E-15 |
0.568 |
0.731 |
| PPIL3 |
Q9H2H8
|
peptidylprolyl isomerase like 3
|
Enzyme
|
0.90 |
0.751 |
0.269 |
| RFX7 |
Q2KHR2
|
regulatory factor X7
|
Enzyme
|
1.00 |
0.780 |
0.385 |